EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pan-cancer analysis of genes involved in choline metabolism, focusing on the prognostic and immunological effects of oral squamous cell carcinoma

Tengzhe Dong, Xinuo Zhang, Fanbiao Meng, Hongrui Chen, Yunhan Chang, Borui Zhao, Yamei Han, Xin Hu

Frontiers in Oncology · 18.11.2026 · 16

DOI: 10.3389/fonc.2026.1938504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 18.11.2026. Verfasst von Tengzhe Dong und 7 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Choline metabolism-related genes (CMRGs) have been implicated in tumor progression; however, their pan-cancer roles and implications in oral squamous cell carcinoma (OSCC) remain poorly understood. In this study, we systematically examined the prognostic and immunological significance of CMRGs across cancers, with a focus on OSCC.

Methods

We analyzed CMRG data for 33 TCGA tumor types for pan-cancer differentially expressed genes (DEGs), genes associated with overall survival (OS), genetic variants, and Hallmark pathways. Univariate Cox regression analysis was used to identify OSCC prognostic genes, which were then cross-analyzed with DEGs to build a prognostic model. OSCC patients were divided into high-/low-risk groups by risk score, followed by independent prognostic analysis, immune infiltration assessment, and gene set enrichment analysis (GSEA). Validation was performed using RT-qPCR, Western blot, and immunohistochemistry on OSCC cell lines and tissue microarrays.

Results

CMRGs were differentially expressed in most cancer types, and risk-associated genes outnumbered protective genes in the prognostic analyses. Single-nucleotide variants, predominantly missense mutations, were detected in various tumors. The CMRG scores were significantly positively correlated with the PI3K-AKT-mTOR, heme metabolism, xenobiotic metabolism, and Hedgehog signaling pathways. MAPK9, PDGFA, PRKCA, and DGKH were used to construct an OSCC risk model. Time-dependent receiver operating characteristic analyses in the TCGA-OSCC training set and the GSE41613 validation cohort revealed moderate discrimination (AUC > 0.6). The risk score was associated with OSCC and was independently associated with prognosis in a multivariable Cox analysis. Further analyses revealed a lower ssGSEA score for activated CD8 + T cells in the high-risk group. The TIDE algorithm suggested that the predicted immunotherapy response was poorer in this group. Predicted IC 50 values also differed between the high/low-risk groups.

Conclusion

CMRGs are associated with expression patterns across multiple cancer types and prognostic features in OSCC. The four-gene signature (MAPK9/PDGFA/PRKCA/DGKH) derived from the database-annotated CMRG set was associated with OS and immune-related scores in OSCC and displayed a potential for risk stratification. This study provided a preliminary basis for further evaluating the biological basis of CMRG-related expression patterns and their value for OSCC risk stratification.

Zitieren

APA

Dong, T., Zhang, X., Meng, F., Chen, H., Chang, Y., Zhao, B., Han, Y., & Hu, X. (2026). Pan-cancer analysis of genes involved in choline metabolism, focusing on the prognostic and immunological effects of oral squamous cell carcinoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1938504

Vancouver

Dong T, Zhang X, Meng F, Chen H, Chang Y, Zhao B, et al. Pan-cancer analysis of genes involved in choline metabolism, focusing on the prognostic and immunological effects of oral squamous cell carcinoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1938504

BibTeX
@article{Dong2026,
  author = {Dong, Tengzhe and Zhang, Xinuo and Meng, Fanbiao and Chen, Hongrui and Chang, Yunhan and Zhao, Borui and Han, Yamei and Hu, Xin},
  title = {Pan-cancer analysis of genes involved in choline metabolism, focusing on the prognostic and immunological effects of oral squamous cell carcinoma},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1938504}
}
Kostenlos starten →